Ms. Jing Xiao focuses on investing in biotech, medical services, and healthcare. The sub-sectors she is interested in include new drug modalities and therapy development, interdisciplinary innovation in biotech applications, and novel platform-based technologies such as synthetic biology. She has over 3 years of healthcare investment experience plus startup experience at a digital healthcare company. Companies she invested in include Trifo, Joint Therapeutics, Rootpath and Revir Therapeutics. She is also responsible for the management of the fund’s healthcare investments.

Previously, she worked at TusStar and Yidu Cloud.

Jing holds a Ph.D. from the School of Medicine and a B.S. from the School of Life Sciences of Tsinghua University.